Biotherapeutics

During the course you’ll learn about immunology, oncology, vascular biology and neuropathology. You’ll also gain the vital skills and know-how needed to develop and manufacture biotherapeutics to improve patient outcomes and healthcare delivery, for example through the use of facilities at the state-of-the-art National Institute of Bioprocessing Research and Training (NIBRT).



Benefit from a mix of learning formats

The course includes a mix of study and assessment formats – such as in-class discussions, peer review, projects and presentations – to give you a diverse and engaging learning experience. Towards the end of the programme, you’ll undertake a research project in an internal or external research group, or at your workplace.



Once you graduate, you’ll be sought after for roles in biotherapeutics, academia and healthcare. You’ll also be an ideal candidate for BioTranslate, the structured PhD research programme in the DCU School of Biotechnology.



Programme Structure

Multidisciplinary in nature, this programme appeals to a wide range of candidates from across sectors who work with or are planning to work with biomedical therapeutics, including but not limited to life scientists, professionals from the Biopharma and BioPharmaceutical, Biotechnology, Diagnostics and/or Healthcare industries and medical practitioners (including GPs, clinicians-in-training, and specialist nurses).



Graduates will be well placed to provide practice, professional leadership, innovation and scholarship expertise to a vast array of organisations to make a difference in the development and application of biotherapeutics.

To qualify for the MSc in Biotherapeutics programme students will be expected to have a Second Class Honours degree (H2.1) or equivalent in a life science, pharmaceutical or chemistry discipline. Medical graduates must have a MB, BCh, BAO or equivalent from a recognised medical school.



Applicants with equivalent qualifications in related areas of science and technology, or with proven and relevant industrial experience from the Healthcare/Medical/Therapeutics industry may be considered for places following interview and assessment by the programme management team, in line with standard DCU policies.



Recognition of Prior Learning (RPL) applicants are required to submit a cover letter along with their application under the Transcripts section of the portal, affirming their intent to apply for RPL. RPL applicants may be required to attend for interview. For more information on RPL see here.



International candidates who are non-native speakers of English must satisfy the University of their competency in the English language. More information about DCU's English language requirements can be found here.

1 year full-time or 2 years part-time.

Careers

Graduates of this programme will be well placed to provide practice, professional leadership, innovation and scholarship expertise to a vast array of organisations to make a difference in the development and application of biotherapeutics; such as in academia, health care, industry settings, and many more.



The programme is designed to enhance postgraduate students’ employability and promotional aspects through the improvement of skills and knowledge of the pathophysiology of disease and the development of next generation of biologics therapies.



Lastly, graduates of this programme would be ideal candidates for the structured PhD research programme (BioTranslate) within the School.